At the news
? BULLISHIMPACT 7/10 8-K filed Jul 30, 2026 at 07:17 ET
Baxter reported Q2 2026 results that significantly exceeded consensus expectations, with adjusted EPS of $0.56 (vs $0.37 consensus, +51.4% beat) and revenue of $2.96B (vs $2.80B consensus, +5.7% beat). The company raised its full-year 2026 guidance: reported sales growth now 3-4% (from flat to 1%), organic sales growth 2-3% (from approximately flat), and adjusted EPS $1.95-$2.15 (from $1.85-$2.05). The beat was partly driven by a $0.11/share IEEPA tariff refund not previously contemplated in guidance.
- Q2 2026 adjusted EPS $0.56 vs consensus $0.37 (+51.4% beat)
- Q2 2026 revenue $2.96B vs consensus $2.80B (+5.7% beat)
- Revenue grew 5% YoY on both reported and organic basis, with all segments and divisions growing
- Full-year 2026 guidance raised: reported sales growth 3-4% (from flat to 1%), organic sales growth 2-3% (from approximately flat), adjusted EPS $1.95-$2.15 (from $1.85-$2.05)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access